VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NNVC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NNVCNanoViricides, Inc.
$1.35$24M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNNVCQuarterly Financials

NanoViricides, Inc. (NNVC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

NanoViricides, Inc. (NNVC) quarterly income statement — complete revenue, gross profit & net income history

NNVC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold129.63K000000000000000000176.16K
COGS % of Revenue--------------------
Gross Profit-129.63K000000000000000000-176.16K
Gross Margin %--------------------
Gross Profit Growth %---------------100%----
Operating Expenses1.9M2.23M1.8M2.12M2.25M2.06M3.17M2.39M1.91M2.18M2.03M3.68M1.81M1.83M1.62M1.79M1.79M1.92M2.61M1.9M
OpEx % of Revenue--------------------
Selling, General & Admin744.28B1.11M803.62K938.2K966.9K902.7K1.23M1.21M693.74K610.88K564.93K763.42K614.65K663.28K509.7K621.22K532.8K659.27K515.45K314.01K
SG&A % of Revenue--------------------
Research & Development1.29T1.12M993.07K1.18M1.28M1.16M1.93M1.18M1.21M1.57M1.47M2.91M1.2M1.17M1.11M1.17M1.26M1.26M2.1M1.58M
R&D % of Revenue--------------------
Other Operating Expenses-1000K0000000000000000000
Operating Income-2.03M-2.23M-1.8M-2.12M-2.25M-2.06M-3.17M-2.39M-1.91M-2.18M-2.03M-3.68M-1.81M-1.83M-1.62M-1.79M-1.79M-1.92M-2.61M-2.07M
Operating Margin %--------------------
Operating Income Growth %9.73%-8.46%43.28%11.53%-17.86%5.75%-55.93%34.95%-5.39%-19.13%-25.22%-105.07%-1.28%4.51%37.9%13.57%15.17%16.2%-15.06%-13.24%
EBITDA-1.9M-2.1M-1.66M-1.95M-2.06M-1.86M-2.97M-2.2M-1.72M-2M-1.84M-3.49M-1.62M-1.65M-1.44M-1.6M-1.61M-1.74M-2.44M-1.9M
EBITDA Margin %--------------------
EBITDA Growth %7.65%-12.72%44.02%11.19%-19.76%6.63%-61.32%36.9%-5.92%-21.15%-28.04%-117.31%-1%5.51%40.93%15.45%16.83%17.65%-16.38%-14.56%
D&A (Non-Cash Add-back)129.63K133.08K132.82K161.13K191.18K195.88K195.61K190.6K189.96K189.33K189.12K188.88K188.32K186.92K183.4K187.96K181.56K177.39K176.42K176.16K
EBIT-2.03M-2.22M-1.79M-2.1M-2.22M-2.03M-3.13M-2.39M-1.85M-2.1M-1.93M-3.68M-1.7M-1.75M-1.57M-1.79M-1.79M-1.92M-2.61M-2.07M
Net Interest Income40.88K12.46K11.63K19.72K32.37K31.56K41.02K35.37K53.93K69.82K62.84K106.38K107.94K88.86K51.72K0-4.79K-558-7031.39K
Interest Income40.88K12.46K11.63K19.72K32.37K31.71K41.02K35.37K53.93K83.13K99.34K106.38K107.94K88.95K52.56K002.07K1883.08K
Interest Expense0000014900013.31K36.49K00084404.79K2.63K8911.69K
Other Income/Expense40.88K12.46K11.63K19.72K32.37K31.56K41.02K35.37K53.93K69.82K62.84K106.38K107.94K88.86K51.72K12.79K-4.79K-558-7031.39K
Pretax Income-1.99M-2.22M-1.79M-2.1M-2.22M-2.03M-3.13M-2.36M-1.85M-2.11M-1.97M-3.57M-1.7M-1.75M-1.57M-1.78M-1.79M-1.92M-2.61M-2.07M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.99M-2.22M-1.79M-2.1M-2.22M-2.03M-3.13M-2.36M-1.85M-2.11M-1.97M-3.57M-1.7M-1.75M-1.57M-1.78M-1.79M-1.92M-2.61M-2.07M
Net Margin %--------------------
Net Income Growth %10.26%-9.53%42.91%11.04%-19.54%4.13%-58.82%34.01%-8.91%-21.19%-25.35%-100.56%5.01%9.16%39.89%14.13%14.96%17.55%-13.06%-10.58%
Net Income (Continuing)-1.99M-2.22M-1.79M-2.1M-2.22M-2.03M-3.13M-2.36M-1.85M-2.11M-1.97M-3.57M-1.7M-1.75M-1.57M-1.78M-1.79M-1.92M-2.61M-2.07M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.09-0.11-0.10-0.13-0.14-0.14-0.23-0.20-0.16-0.18-0.17-0.31-0.14-0.14-0.13-0.15-0.16-0.17-0.23-0.19
EPS Growth %34.21%21.43%56.52%35%12.5%22.22%-35.29%35.48%-14.29%-28.57%-30.77%-106.67%12.5%17.65%43.48%21.05%15.79%22.73%-4.55%-5.56%
EPS (Basic)-0.09-0.11-0.10-0.13-0.14-0.14-0.23-0.20-0.16-0.18-0.17-0.31-0.14-0.14-0.13-0.15-0.16-0.17-0.23-0.19
Diluted Shares Outstanding21.61M19.85M17.08M16.51M16.03M14.57M13.72M11.87M11.78M11.75M11.72M11.7M11.64M11.61M11.59M11.56M11.54M11.53M11.52M10.95M
Basic Shares Outstanding21.61M19.85M17.08M16.51M16.03M14.57M13.72M11.87M11.78M11.75M11.72M11.7M11.64M11.61M11.59M11.56M11.54M11.53M11.52M10.95M
Dividend Payout Ratio--------------------